
22 July 2024: Genea celebrates 38 years of ‘first’ pioneering innovations this World IVF Day
Dean Morbeck, Scientific Director at Genea, was featured in Mum's Grapevine discussing how artificial intelligence and recent IVF innovations are revolutionising reproductive medicine and improving success rates for families seeking fertility treatment.
The article explores 11 groundbreaking IVF innovations that have transformed fertility care over the past half-century. Several of these innovations were pioneered by Genea, demonstrating the organisation's leadership in advancing reproductive technology globally.
Genea's contributions to IVF innovation include developing the first individual chamber time-lapse incubator, known as Geri™, which is exclusive to Genea patients in Australia and has been sold globally. This technology provides enhanced embryo monitoring and has improved both embryo quality and success rates. Genea was also the first clinic to adopt Day 5 embryo transfer as a standard protocol—a breakthrough that nearly doubled success rates overnight and became a new industry benchmark globally.
Additionally, Genea pioneered the creation of the first benchtop incubator, setting new standards in embryo cultivation during IVF's early years. The organisation established Australia's first dedicated egg-freezing clinic, offering women enhanced reproductive options and greater control over family planning. Genea also launched the world-first embryo viewing app, Grow by Genea™, allowing patients to view and track their embryos as they develop in the lab, enhancing transparency and engagement in the IVF process.
Looking to the future, Dean emphasises the transformative potential of artificial intelligence in reproductive medicine. "As we look to the future, the intersection of IVF and artificial intelligence is set to revolutionise reproductive medicine even further," he explains. "AI has the potential to enhance every aspect of the IVF process—from optimising embryo selection to personalising patient care. By harnessing the power of AI, we aim to refine our techniques, increase success rates, and ultimately make the dream of parenthood more accessible to many more families."
The article acknowledges that while infertility journeys can be challenging, ongoing innovations continue to provide hope and expanded options for families.